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Background: Escherichia coli strains lacking the phosphoenolpyruvate: carbohydrate phosphotransferase system
(PTS), which is the major bacterial component involved in glucose transport and its phosphorylation, accumulate
high amounts of phosphoenolpyruvate that can be diverted to the synthesis of commercially relevant products.
However, these strains grow slowly in glucose as sole carbon source due to its inefficient transport and metabolism.
Strain PB12, with 400% increased growth rate, was isolated after a 120 hours adaptive laboratory evolution process
for the selection of faster growing derivatives in glucose. Analysis of the genetic changes that occurred in the PB12
strain that lacks PTS will allow a better understanding of the basis of its growth adaptation and, therefore, in the
design of improved metabolic engineering strategies for enhancing carbon diversion into the aromatic pathways.
Results: Whole genome analyses using two different sequencing methodologies: the Roche NimbleGen Inc.
comparative genome sequencing technique, and high throughput sequencing with Illumina Inc. GAIIx, allowed the
identification of the genetic changes that occurred in the PB12 strain. Both methods detected 23 non-synonymous
and 22 synonymous point mutations. Several non-synonymous mutations mapped in regulatory genes (arcB, barA,
rpoD, rna) and in other putative regulatory loci (yjjU, rssA and ypdA). In addition, a chromosomal deletion of
10,328 bp was detected that removed 12 genes, among them, the rppH, mutH and galR genes. Characterization of
some of these mutated and deleted genes with their functions and possible functions, are presented.
Conclusions: The deletion of the contiguous rppH, mutH and galR genes that occurred simultaneously, is
apparently the main reason for the faster growth of the evolved PB12 strain. In support of this interpretation is the
fact that inactivation of the rppH gene in the parental PB11 strain substantially increased its growth rate, very likely
by increasing glycolytic mRNA genes stability. Furthermore, galR inactivation allowed glucose transport by GalP into
the cell. The deletion of mutH in an already stressed strain that lacks PTS is apparently responsible for the very high
mutation rate observed.
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Figure 1 Isolation of the evolved PB12 strain. The isolation of
PB12 has previously been reported and is included to provide
orientation to the reader and for discussion purposes [10]. The
evolutionary process that generated the PB12 strain initiated with
the parental PB11 strain that lacks the PTS system. Deletion of this
system generates a carbon stress response when PB11 is grown in
glucose as the sole carbon source [9,13]. This strain that grows very
slowly in glucose and generates white colonies (WC) in glucose-
McConkey agar plates, was grown in a batch culture fermentor
containing minimal medium with 2 g/l of glucose as the sole
carbon source and 30 μg/ml of kanamycin. Under these conditions,
a selection pressure is generated, favoring faster growing mutants.
The culture was maintained until the stationary phase and then a
continuous culture was initiated by feeding a glucose solution at
progressively higher dilution rates in the same medium. Dotted line
indicates the end of the batch culture and the start of the
continuous culture. This procedure allowed the isolation of mutants
according to their growth rates. Samples were monitored on
glucose-McConkey agar plates to identify red colonies as an
indicative of glucose utilization [Glc+] phenotype. Red colonies (RC)
were detected after a period of 70 hr. The arrows indicate the
isolation time for several Glc+ variants including PB12. Numbers
indicate different dilution rates (D = h-1). All the isolated colonies
from this culture carry the same large deletion present in strain PB12
(data not shown). This figure was derived and modified from
figure 1 from Flores et al. 2007 [10].
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Genome changes including point mutations, duplica-
tions, and recombination with homologous and heterol-
ogous DNA are the driving force of evolution. Bacteria,
the most diverse and adapted types of cells in the bio-
sphere, have permanently been evolving during millions
of years to survive different environmental changes.
Comparative genomics is a very powerful tool to analyze
bacterial evolution occurring over short periods of time
[1-3]. Moreover, whole genome resequencing of evolved
Escherichia coli strains using simultaneously two differ-
ent methodologies has recently been reported. This
strategy is certainly very useful for understanding bacter-
ial evolution, such as pathogen emergence, adaptation to
environmental perturbations or during fermentation
events used to generate derivative strains with enhanced
industrial capacities [3-5].
We have constructed and characterized Escherichia
coli strains that lack the phosphoenolpyruvate: carbohy-
drate phosphotransferase system (PTS), by deletion of
the ptsH, ptsI, and crr genes, which is the major bacterial
component involved in glucose transport and its phos-
phorylation. One of these strains, PB11, in spite of
growing very slow in glucose (with a specific growth
rate (μ) = 0.1 vs. 0.7 h-1 as compared to the parental
strain JM101), accumulates high amounts of phosphoe-
nolpyruvate, which can be diverted to the synthesis of
aromatic compounds. PTS deletion results in a carbon
stress response when the PB11 strain is grown in glucose
as the sole carbon source that induces carbon scaven-
ging. Strains lacking PTS can co-utilize several carbon
sources due to the lack of catabolite repression exerted
by PTS, and their glycolytic flux is reduced as part of a
carbon limitation response [6-13]. As a metabolic engin-
eering strategy, an adaptive laboratory evolution process
for the selection of faster growing derivatives of the PB11
strain was carried out in a fermentor in minimal medium
with glucose as the sole carbon source. In this process,
after entering the stationary phase this carbohydrate was
fed by progressively increasing the dilution rate. The
resulting strain, PB12, which achieved a very reasonable
growth rate (μ= 0.44 h-1), was selected in a process that
lasted 120 hours (hr) (Figure 1) [9,10,12,13]. The evolved
PB12 strain that in the absence of PTS uses the galactose
permease (GalP), as the parental PB11 strain for glucose
transport, has been utilized for overproduction of aro-
matic compounds [7,9,12,14-17].
It is well known that E. coli cells can adapt their me-
tabolism to achieve higher growth rates as a result of
specific mutations [2,5,18]. To get insights of the faster
growth of the PB12 strain, we have compared its tran-
script levels with those of the parental PB11 strain,
by reverse transcriptase quantitative real time PCR
(RT-qPCR), of critical metabolic pathways. Interestingly,we found that all glycolytic and several other central car-
bon metabolism genes, including those that code for the
tricarboxylic acid (TCA) cycle enzymes, are overexpressed,
suggesting a very efficient carbon utilization by the
evolved strain [7-13,19]. We have previously shown that a
mutation in the arcB gene could be responsible for the
overexpression of the TCA genes [9,20-22]. In addition a
second mutation responsible of amber stop codon at pos-
ition 98 in the rpoS gene which codes for the sigma factor
RpoS, was detected in PB12 when compared against
strain MG1655 [9,11]. Nevertheless, to get a detailed
knowledge at the molecular level, of all the different
genetic changes that occurred in the PB12 strain, a
complete genomic analysis is required. This informa-
tion will allow a better understanding of the basis of
growth adaptation, plasticity, and the physiology of
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the design of improved laboratory adaptive evolution
and metabolic engineering strategies for enhancing
carbon diversion into the aromatic pathway utilizing
strains lacking PTS.
In this work, using the Roche NimbleGen Inc. com-
parative genome sequencing technique (CGS) and high
throughput sequencing with Illumina Inc. GAIIx, we
identified all the genetic changes that occurred in the
evolved PB12 strain during the selection process and
analyzed and characterized the most relevant ones.
Results of the whole genome sequencing, supported by
transcript quantification by RT-qPCR and by knockout
inactivation of selected genes in the parental PB11
strain, indicate that a simultaneous deletion of several
contiguous genes including rppH, mutH and galR, is the
main reason for the fast growth in glucose. galR codes
for the repressor of the gal operon that includes galP
that codes for the GalP permease [23], rppH codes for
the RNA pyrophosphohydrolase (RppH), which initiates
mRNA degradation [24], while mutH codes for the
endonuclease of the MutHLS system involved in the
mismatch DNA repair system [25]. In addition, several
non-synonymous point mutations were detected as one
located in the RNase I coding gene rna, involved in the
degradation of RNA [26,27], while others were located
in known and in putative regulatory genes, such as arcB
[21,22], barA [28,29] rpoD [30], rssA [31] and yjjU
[32,33]. Finally, other mutation was mapped on ypdA,
which code for a putative histidine kinase [34].
Results and discussion
Detection and characterization of non-synonymous point
mutations in the evolved PB12 strain
Two comparative whole genome nucleotide sequence
analyses of the evolved PB12, its parental JM101, and
the wild type K-12 MG1655 strains were performed.
The first was carried out by Roche NimbleGen Inc.,
Madison, WI (RN), using their CGS method; the sec-
ond analysis was developed by Winter Genomics Inc.,
Mexico City (WG), using Illumina’s massively parallel
sequencing technology (see Materials and Methods). In
the RN analysis, 26 non-synonymous point mutations
were detected in structural genes; 21 of them were also
mapped at the same positions by WG. In addition, 6
non-synonymous mutations were detected only by WG
(Table 1A and Tables S1 and S2 presented in Additional
file 1 and Additional file 2). Since there was some dis-
crepancies between the two technologies that utilized
DNA obtained from the original frozen stock of the
PB12 strain (see Materials and Methods), we decided to
sequence each of the mutant genes solely reported by
one company, after PCR amplification using the Sanger
methodology. Only two of the mutants detected by WG(in the csgF and ytfR genes) could be confirmed by San-
ger resequencing. The mutations in the other four genes
(ftsK, stfE, C0362 and rsxC) reported by WG and the five
other genes (mdlB, yagN, ydfN, ykfA and yagG) reported
by RN (Tables S1 and S2 presented in Additional file 1
and Additional file 2), could not be confirmed by the San-
ger methodology (data not shown). Therefore, the total
number of non-synonymous point mutations detected,
comprised 21 reported by both companies, plus 2
additional mutations reported only by WG. 14 of the
21 common mutations including the ones located in
regulatory genes (see below), were confirmed by San-
ger resequencing (Table 1A). Recently, it has been
shown that when both types of methodologies were
utilized simultaneously for whole genome resequen-
cing of E. coli strains in which growth adaptations by
evolution occurred, both techniques reported false
positive mutations [4,5]. Therefore, it is likely that the
mutations in the PB12 strain not confirmed by the
Sanger methodology are false positives. However,
since the mutH gene deletion in this strain is respon-
sible of increasing the mutation rate in E. coli [35]
(see below), it could be possible that the two non-
synonymous mutations detected only by WG, and
confirmed by Sanger, are due to de novo changes that
occurred in the overnight culture utilized to obtain
DNA for genome analysis by WG and not in the fermenta-
tion process started with the PB11 strain (Figure 1). Alter-
natively, these two mutations could be real, but they were
not detected by the RN analysis. Importantly, the nucleo-
tide sequence of the parental PB11 strain was also deter-
mined by WG (data not shown). None of the point
mutations that occurred in PB12 were detected in PB11,
indicating that they appeared in the laboratory adaptive
evolution process.
Among the non-synonymous substitutions detected
some were located at genes with regulatory functions:
arcB, barA, rpoD, rna, and three in putative regulatory
genes: yjjU, rssA and ypdA (Table 1A). The mutation in
the arcB gene, a tyrosine to cysteine residue substitution
at position 71 that apparently modifies the ArcA/B abil-
ity to function as a repressor, has previously been
reported by our group. We have proposed that this
modification could be responsible for the overexpression
of the TCA genes in the PB12 derivative as compared to
the parental PB11 strain [9,20,21] (Table 1A). A new role
for this mutation is proposed (see next sections).
The barA mutation resulted in a phenylalanine to leu-
cine residue substitution at position 366 (Table 1A). This
residue is located between two functional subregions of
the HK domain of this protein; the “H box”, where the
conserved histidine residue involved in the autopho-
sphorylation of BarA is located, and the “N box”,
involved in ATP binding [28,29].
Table 1 Mutations that occurred in the evolved PB12 strain during the adaptive process
A) Gene Basic description Mutations
Hypothetical genes JM101 and
PB11
PB12 Nucleotide Pos/Change
gfcD* Hypothetical lipoprotein. GTA cTA 916 306 V-L
yafV* Predicted C-N hydrolase family amidase, NAD(P)-binding. CGC CaC 452 151 R-H
+ytfR (WG) Putative ATP-binding component of a galactose ABC transporter. GTC GcC 602 201 V-A
Metabolism and Transport JM101 and
PB11
PB12 Nucleotide Pos/Change
+actP* Acetate/glycolate permease in the solute:sodium symporter (SSS) family. GTA GcA 731 244 V-A
arnT* L-Ara4N transferase catalyzes addition of L-Ara4N to lipid A under some conditions. TAC TgC 1193 398 Y-C
+chbC* Integral membrane transport protein, member of the chitobiose PTS transporter. GCG GtG 347 116 A-V
+csgF(WG) Curli secretion and assembly complex. AAU AgU 89 30 N-S
+dgoT* Probable galactonate transporter, member of the major facilitator superfamily
(MFS) of transporters.
GAT GgT 653 218 D-G
dhaM* Dihydroxyacetone kinase subunit M, homologous to certain PTS components. TGG TGa 1038 346 W-stop
+dppF* ATP-binding component of the dipeptide ABC transporter. CAC CgC 680 227 H-R
fdhD* Protein with unknown function, required for wild-type formate
dehydrogenase-N activity.
AGT gGT 652 218 S-G
fimH* Minor fimbrial subunit, D-mannose specific adhesin, subunit of fimbrial complex. ACT gCT 535 179 T-A
glpT* Major uptake transporter for glycerol-3-phosphate, belongs to the major
facilitator superfamily (MFS).
CCG CtG 416 139 P-L
rfe* Undecaprenyl-phosphate α-N-acetylglucosaminyl transferase . GCC aCC 238 80 A-T
+sucA* E1(0) component of the oxoglutarate dehydrogenase complex. GAT GAa 372 124 D-E
ydiQ* Putative subunit of YdiQ-YdiR flavoprotein. GTG GcG 218 73 V-A
Regulatory and putative regulatory genes JM101 and
PB11
PB12 Nucleotide Pos/Change
+arcB* Hybrid protein sensory kinase, member of two-component system. TAC TgC 212 71 Y-C
+barA* Hybrid protein sensory kinase, member of two-component system. TTC cTC 1096 366 F-L
+rna* RNase I, cleaves phosphodiester bond between any two nucleotides. GCC aCC 268 90 A-T
+rpoD* Sigma 70 factor, subunit of RNA polymerase. GTT aTT 1744 582 V-I
+rssA* Hypothetical protein, coded by a gene that is part of the rssAB operon. CGC CaC 773 258 R-H
+yjjU* Conserved hypothetical protein, could work as a transcriptional protein. ACT gCT 338 179 T-A
+ypdA* Predicted sensory kinase member of two-component system. GCG tCC 598 200 A-S
B) Gene Basic description Mutations
ptsP Member of a second PTS chain involved in nitrogen metabolism Present Absent — —
rppH RNA pyrophosphohydrolase that initiates mRNA degradation by
hydrolysis of the 5'-triphosphate end.
Present Absent — —
ygdT Hypothetical protein. Present Absent — —
mutH dGATC endonuclease in the MutHLS complex, the methyl-directed
mismatch repair pathway.
Present Absent — —
ygdQ Putative transport protein. Present Absent — —
ygdR Predicted protein. Present Absent — —
tas Putative NAD(P)-linked reductase that acts in starvation-associated mutations. Present Absent — —
lplT Lysophospholipid transporter (LplT). Present Absent — —
aas 2-acylglycerophosphoethanolamine acyltransferase/acyl-ACP synthetase. Present Absent — —
omrA Small RNA that is involved in regulating the protein composition of
the outer membrane.
Present Absent — —
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Table 1 Mutations that occurred in the evolved PB12 strain during the adaptive process (Continued)
omrB Small RNA that is involved in regulating the protein composition of
the outer membrane.
Present Absent — —
galR DNA-binding transcription factor; represses transcription of the operons
involved in transport and catabolism of D-galactose.
Present Absent — —
Table 1A presents the 23 non synonymous point mutations in structural genes that changed the code for a different amino acid when compared to the parental
PB11 and JM101 strains genomes. The asterisks in the table indicate the 21 non-synonymous point mutations detected by both Roche NimbleGen Inc. (RN) and
Winter Genomics Inc. (WG) methods. In addition 22 synonymous point mutations in different genes were also detected (Tables S1 and S2 in Additional file 1 and
Additional file 2). The regulatory and possible regulatory genes analyzed in this study are in bold letters. The mutations in these seven regulatory and possible
regulatory genes and in seven additional genes were confirmed by the Sanger methodology and are labeled with a +. 26 (21+5) point mutations in 26 genes
were detected by RN, 5 of them were false positive. 27 (21+6) point mutations in 27 genes were detected by WG. In addition to the 21 mutations shared with RN,
only two of these point mutations (noted as WG) were confirmed by the Sanger methodology. Additional file 1 and Additional file 2 (Tables S1 and S2) include
the data from RN and WG. Table 1B presents the absent genes in the largest deletion reported by both companies. (Figures. 2, 3, 4 and S1, presented in
Additional file 3). Basic descriptions of these genes were taken from www.ecocyc.org.
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isoleucine residue substitution at position 582, which is
located in a helix-turn-helix (HTH) motif of the RpoD
coded protein (Table 1A). This motif is involved in the
binding to the −35 promoter region, but it is unlikely
that the conservative nature of the substitution, and the
fact that this residue does not make any direct contact
with the DNA [36], had any significant effect on pro-
moter recognition.
The mutation in the rna gene, an alanine to threonine
residue substitution at position 90 of the coded RNase I,
is also unlikely to have any consequence, since it is
located in a nonconserved structural part outside the
catalytic region [37].
The yjjU mutation resulted in a threonine to alanine
residue substitution at position 179 in the coded YjjU
protein (Table 1A). It has been proposed that this pro-
tein could have a regulatory role [32,33].
The mutation in the rssA gene resulted in an arginine
to histidine residue substitution at position 258 of its
product. The importance of this mutation, as well as the
function of the RssA protein, are unknown; however, it
might be functionally related to the RssB protein, which
is involved in the degradation of the RpoS, since both
conserved proteins are coded by genes located in the
same operon [31]. An esterase function has also been
predicted for RssA [Uniprot.org].
The point mutation in the ypdA gene located at pos-
ition 200, caused an alanine to serine residue substitu-
tion. This gene codes for a predicted sensory histidine
kinase of the two-component system YpdA-YpdB [34].
The products of most of the other mutated genes
(sucA, dhaM, ydiQ, chbC, glpT, arnT, dppF, rfe, fdhD,
fimH, csgF, dgoT, and actP) detected by both companies
and the two mutations detected only by WG (csgF and
ytfR), are involved in bacterial metabolism and transport
(Table 1A).
In addition, 22 synonymous mutations were reported;
16 of them detected by both companies. These mutations
were not analyzed since it is unlikely that they could have
any significant effect on the phenotype (Tables S1 and S2in Additional file 1 and Additional file 2). Also, several
point mutations were detected in non-coding regions by
WG. It should be noted that these unconfirmed muta-
tions are unlikely to be located in regulatory regions
(data not shown).
The presence of a mutation in the rpoS gene in the
PB12 strain has been reported. This change generates a
stop codon instead of a glutamine coding residue at pos-
ition 98. It is known, that this strain being a derivative of
JM101, carries a supE mutation, which suppresses amber
stop codons [11,38,39]. Originally this mutation was
considered to have occurred during the adaptive evolu-
tion process since the change was detected when com-
pared against the sequence of strain MG1655 [9,11,40].
However, both comparative genome sequencing strat-
egies showed that this mutation was already present in
the parental PB11 and the JM101 strains. Sanger rese-
quencing confirmed the presence of this mutation in
both of the parental strains (data not shown). So, this
mutation was incorporated at sometime during the de-
velopment of the JM101 strain from its parental strains
JC3130, CSH51 and 71.18 [38,39].
Detection, characterization of a chromosomal deletion in
the evolved PB12 strain, and analysis of the effects of the
deleted genes
A deletion of 10,328 bp located at minute 64 on the
chromosome of the PB12 strain that removed simultan-
eously the rppH, ygdT, mutH, ygdQ, ygdR, tas, lplT, aas,
omrA, omrB, and the part of ptsP and galR genes, was
detected by both RN and WG analyses (Table 1B and
Figure 2). This deletion was confirmed by PCR (Figure 3)
and its limits mapped within the ptsP and galR genes,
resulting in a fusion of the remaining segments of these
two genes (Figure 4). The nucleotide sequence of the
fused fragments was confirmed by Sanger and it is pre-
sented in Additional file 3 (Figure S1). Neither repeated
sequences nor insertion sequences were detected in the
chromosomal DNA regions flanking the deleted genes;
therefore, the molecular bases of this deletion are
unknown.
Figure 2 Comparative genomic maps of the JM101 and PB12 strains. Deletions detected in the PB12 strain. The small deletion is the result
of the elimination of the PTS genes (ptsH, ptsI and crr) that was previously generated in the parental PB11 strain [7,9]. The largest of these
deletions appeared during the laboratory adaptive evolution process (Figures 3 and 4).
Aguilar et al. BMC Genomics 2012, 13:385 Page 6 of 17
http://www.biomedcentral.com/1471-2164/13/385The analyses of three of these genes, galR, mutH and
rppH whose deletion could be the main cause (see below)
of the faster growth in glucose of the evolved PB12 strain
is presented and discussed in the following sections.
The galR gene codes for the repressor of the gal regulon
that includes the galP gene [23]. Therefore, the inactivation
of this gene in the PB12 strain is apparently responsible for
the high transcription levels of most of the gal genes. In
agreement with this proposition, we have previously
demonstrated that the PB12 strain that lacks PTS is
dependent on GalP for glucose transport [9,12].
The rppH gene codes for an RNA pyrophosphohydro-
lase that initiates mRNA degradation by hydrolysis of
the 5’ triphosphate-end. After this modification, RNase E
can initiate further mRNA degradation. It has been
reported that the level of 382 transcripts increased sig-
nificantly in E. coli cells lacking RppH [24]. Accordingly,
in the PB12 strain higher transcript levels of many genes,
among them glycolytic and TCA genes were detected by
RT-qPCR as compared to the parental JM101 and PB11
strains. We could not explain the basis of the simultan-
eous “overexpression” of the genes involved in these
metabolic pathways (with the exception of the TCA
cycle genes due to the arcB mutation, as previously
mentioned) [9,11]. In the light of the phenotype of the
strains lacking rppH, it is likely that the higher levels of
the transcripts observed in the PB12 strain is a result of
impaired mRNA degradation instead of overexpression
(see below). In fact, rppH inactivation in the PB11ΔrppH
strain increased its μ 261% (Table 2). In agreement with
this μ increment, as it will be presented in detail in the
next sections, the RT-qPCR values of most central meta-
bolic genes were increased 1.5- to 18-fold when therppH gene was inactivated in the PB11ΔrppH derivative
as compared to the parental PB11 strain, allowing an
improved glucose metabolism, probably due to higher
levels of central metabolic genes transcripts (see next
sections). Interestingly, in contrast to the PB11 strain,
inactivation of the rppH gene in the parental
JM101ΔrppH strain decreased 27% its μ (data not
shown), indicating that this mutation disrupted the glu-
cose metabolism in this strain that does not have
impaired the glucose transport. From these results it is
tempting to speculate that inactivation of rppH could be
considered as a tool for increasing the half-life of certain
mRNAs families, and therefore growth rates, in strains
with certain limited growth conditions.
The absence of the mutH gene, which codes for the
MutH endonuclease that is part of the MutHLS complex
involved in the DNA mismatch repair pathway, is prob-
ably responsible for the appearance of the large number
of mutations detected in the PB12 strain during the
short term adaptive laboratory evolution process that
lasted for only 120 hr [5,7,9,10,12,18,25]. It is known
that the absence of the mutH gene increases the muta-
tion frequency in E. coli at least 200 fold [35]. In
addition, starvation-induced mutagenesis among hun-
dreds of E. coli natural isolates is increased on average
7-fold, but in certain strains up to 1000-fold [41-43].
The presented and analyzed information indicates that
the 21 shared non-synonymous point mutations as well
as the deletion are real mutations that appeared after a
120 hr period in this adaptive laboratory evolution
process. A possible explanation for this high number of
mutations is that the deletion of the mutH, rppH and
galR genes occurred early in the very short laboratory
Figure 3 Chromosomal deletion markers in the PB12 strain. The absence of a chromosomal fragment in the PB12 strain was confirmed by
PCR and by Sanger resequencing. Ten genes were deleted and the galR and ptsP genes were fused. Section A shows the ptsP and galR genes
that were amplified in the JM101, PB11 and PB12 strains: line 1, (M) molecular weight markers; lines 2, 3 and 4, ptsP amplification in the JM101,
PB11 and PB12 strains, respectively; lines 5, 6 and 7, galR amplification in the JM101, PB11 and PB12 strains, respectively; line 8, amplification of
the chromosomal region in the PB12 strain; line 9, (M) molecular weight markers; lines 10, 11 and 12, amplification of the chromosomal region
using DNA from strains JM101, PB11 and PB12, respectively. Section B presents the oligonucleotides utilized for DNA amplifications. The left
section (L) includes the oligonucleotides employed for the amplification of the ptsP and galR genes of the three strains (lines 2–7), and the right
section (R) presents the entire chromosomal regions of the same three strains amplified using ptsP-fwd and galR-rv oligonucleotides (lines 8,
10–12). The nucleotide sequences of the oligos utilized are included in table S3 presented in additional file 4.
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the absence of mutH, some or several of the point muta-
tions could then have occurred during a few replication
cycles, favouring the selection of even faster growing
variants in glucose. In addition, in this genetic back-
ground in which the PTS deletion generates a carbon
stress response, further mutagenesis induction is
expected [9,10,12,41,42,44,45].
RT-qPCR mRNA expression values of relevant mutated
genes and of central metabolic genes in the evolved
PB12 strain
Table 3 shows mRNA expression values of relevant (mainly
regulators or possible regulators) mutated genes and of
some other genes as controls determined by RT-qPCR (see
Materials and Methods). RT-qPCR values of more than 100
genes from the evolved PB12 strain, the parental PB11 andJM101 strains have previously been reported by our group,
including the arcB gene in which a non-synonymous point
mutation appeared, and are presented in Table 3 for
comparison and analyses purposes [9-11]. Results in-
dicate that the RT-qPCR values of some of the regu-
latory and possible regulatory genes were not
substantially modified (except for rpoS and barA) with
respect to the JM101 parental strain. As anticipated,
except for galR, no transcripts of the 12 deleted con-
tiguous genes were detected.
Inactivation of mutated regulatory and putative
regulatory genes in the PB11 and PB12 strains. RT-qPCR
values of carbon central metabolism genes of the
PB11ΔrppH strain
With the aim of understanding the possible roles of
some of the regulatory and possible regulatory genes
Figure 4 Chromosomal gene arrangement in the parental JM101 strain and in the evolved PB12 derivative. A) Gene organization in the
chromosome of the parental strain. B) Gene deletion and chromosome rearrangement in the PB12 strain genome. Figure S1 presented in
Additional file 3, includes the nucleotide sequence of the genomic region where the deletion occurred.
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JM101 strains (Table 1A), they were individually inacti-
vated by a cassette insertion using the Datsenko-Wanner
method [46] (see Materials and Methods), with the
exceptions of the rpoD gene, since its inactivation is le-
thal [47], and the galR gene, since its regulated target,
the galP gene, is already overexpressed in the PB11 and
PB12 strains [9,23]. Interestingly, as shown in Table 2,
individual cassette inactivation of the arcA, rppH, yjjU,
and rssA genes in the PB11 strain increased their specific
growth rates in glucose as the only carbon source,Table 2 Specific growth rates (μ) of the PB11 strain and
its derivatives
Regulatory genes
Strain μ (h-1) %
PB11 0.13 ± 0.001 100
PB11ΔbarA 0.12 ± 0.001 92




Strain μ (h-1) %
PB11ΔyjjU 0.16 ± 0.005 123
PB11ΔrssA 0.17 ± 0.003 130
PB11Δrna 0.13 ± 0.007 100
PB11ΔypdA 0.13 ± 0.002 100
*These values have been previously reported [9-11].supporting our hypothesis that the inactivation of some
of these genes, especially rppH, was the result of direct
selection during the evolution process for faster growth.
Some of these regulatory genes were also inactivated
by the Datsenko-Wanner method in the PB12 strain; the
effects on their respective specific growth rate values are
shown in Table 4. Knockout inactivation of the barA,
arcA, and yjjU genes decreased the μ by about 5%, 10%,
and 23%, respectively, while no substantial growth rate
difference were observed when the rna, rssA, or ypdA
genes were inactivated.
Since the inactivation of the rppH gene in the
PB11ΔrppH strain is responsible for a markedly (261%)
μ increment, the expression of several genes, including
carbon central metabolism, transport and regulators in this
strain, as well as in the JM101ΔrppH strain, were deter-
mined (Table 3). In PB11ΔrppH, most of the RT-qPCR
values of the central metabolism genes, including TCA
(except pgk, fbaA, talB, pckA), increased from 2- to
18-fold, as compared to PB11. RT-qPCR values of all
genes involved in growth under stress-limited carbon
conditions, which most of them are overexpressed in
the PB11 strain due to the lack of PTS (such as the
gal operon, poxB, acs, and the glyoxylate shunt
genes), were also high in the PB11ΔrppH strain and,
for some genes, the increase was up to 10-fold, as for
the maeB gene (Table 3) [8-12]. The mRNA levels of all
these previously mentioned genes, except for aceEF, fbaA,
eno, pckA, pfkA, pykA and pgk, in the PB11ΔrppH strain
were higher than in the parental JM101 strain. Importantly,
Table 3 RT-qPCR values of central metabolism and regulatory genes
Gene PB11* PB12* JM101ΔrppH PB11ΔrppH PB11ΔrpoS* PB12ΔrpoS* PB11ΔarcA*
Glycolysis
aceE + 0.40 ± 0.02 1.40 ± 0.02 1.57 ± 0.23 1.32 ± 0.21 0.20 ± 0.00 0.85 ± 0.00 0.40 ± 0.00
aceF + 0.60 ± 0.00 1.20 ± 0.00 2.66 ± 0.51 1.00 ± 0.12 0.40 ± 0.10 0.70 ± 0.00 0.60 ± 0.00
eno 0.50 ± 0.10 0.50 ± 0.14 0.89 ± 0.01 1.28 ± 0.41 0.20 ± 0.00 0.37 ± 0.00 0.30 ± 0.00
fbaA 0.90 ± 0.00 1.10 ± 0.05 0.82 ± 0.08 1.46 ± 0.18 0.90 ± 0.00 0.37 ± 0.10 0.40 ± 0.00
gapA 0.40 ± 0.10 1.70 ± 0.20 6.98 ± 1.17 3.76 ± 0.67 0.10 ± 0.00 1.40 ± 0.20 0.30 ± 0.00
glk 1.00 ± 0.00 2.20 ± 0.10 3.43 ± 0.72 6.04 ± 0.03 0.70 ± 0.10 1.70 ± 0.10 0.80 ± 0.10
gpmA 0.90 ± 0.00 1.80 ± 0.00 3.07 ± 0.21 2.46 ± 0.13 0.60 ± 0.10 1.70 ± 0.30 0.50 ± 0.00
lpdA + 1.10 ± 0.10 2.00 ± 0.10 2.33 ± 0.00 3.16 ± 0.36 1.30 ± 0.30 1.70 ± 0.10 2.00 ± 0.10
pfkA 0.30 ± 0.00 0.50 ± 0.00 1.49 + 0.11 1.48 + 0.11 0.00 ± 0.00 0.20 ± 0.00 0.10 ± 0.00
pgi 1.00 ± 0.10 6.60 ± 0.30 3.47 ± 0.10 7.71 ± 0.91 0.40 ± 0.10 3.70 ± 0.10 0.40 ± 0.00
pgk 0.70 ± 0.00 1.20 ± 0.00 1.24 ± 0.20 1.08 ± 0.11 N.D. N.D. 0.80 ± 0.00
ppc 0.60 ± 0.05 0.80 ± 0.00 3.81 ± 0.27 1.97 ± 0.40 0.80 ± 0.10 0.50 ± 0.10 N.D.
pykA 0.40 ± 0.00 1.00 ± 0.00 1.16 ± 0.12 0.83 ± 0.03 0.10 ± 0.00 0.51 ± 0.10 0.50 ± 0.10
pykF 0.80 ± 0.00 0.90 ± 0.00 0.89 ± 0.31 2.00 ± 0.26 0.20 ± 0.00 0.50 ± 0.10 0.40 ± 0.00
tpiA 0.50 ± 0.00 1.80 ± 0.00 4.84 ± 0.12 8.83 ± 2.61 0.20 ± 0.00 0.30 ± 0.00 0.40 ± 0.00
Gene TCA cycle
acnA 5.20 ± 0.60 5.70 ± 0.20 2.88 ± 0.31 10.80 ± 1.63 0.70 ± 0.10 3.50 ± 0.30 4.30 ± 0.20
acnB + 1.70 ± 0.36 1.70 ± 0.42 1.76 ± 0.06 24.80 ± 2.18 0.20 ± 0.00 0.70 ± 0.00 2.60 ± 0.30
fumA + 3.30 ± 0.67 3.60 ± 0.67 2.62 ± 0.72 24.07 ± 3.41 2.30 ± 0.50 3.80 ± 0.10 2.10 ± 0.10
gltA + 0.80 ± 0.10 1.30 ± 0.20 1.73 ± 0.31 6.68 ± 0.13 1.30 ± 0.20 1.20 ± 0.20 1.70 ± 0.10
icdA + 1.00 ± 0.10 1.90 ± 0.00 1.03 ± 0.11 4.66 ± 0.78 1.20 ± 0.00 2.40 ± 0.00 1.30 ± 0.00
mdh 1.20 ± 0.10 1.80 ± 0.50 1.93 ± 0.16 3.64 ± 0.32 1.40 ± 0.30 1.40 ± 0.10 1.10 ± 0.10
sdhA + 0.90 ± 0.00 2.00 ± 0.30 4.75 ± 0.98 5.96 ± 0.67 3.70 ± 0.20 4.00 ± 0.00 2.60 ± 0.10
sdhB + 0.80 ± 0.00 1.70 ± 0.00 4.40 ± 0.86 8.05 ± 0.86 2.20 ± 0.00 2.40 ± 0.30 1.30 ± 0.00
sucA + 1.40 ± 0.10 1.70 ± 0.10 3.28 ± 0.20 5.42 ± 1.39 1.20 ± 0.20 1.00 ± 0.00 1.20 ± 0.00
sucB + 0.80 ± 0.00 1.40 ± 0.10 3.31 ± 0.62 8.28 ± 1.91 N.D. N.D. 1.20 ± 0.00
sucC + 0.90 ± 0.10 1.60 ± 0.00 1.99 ± 0.43 7.41 ± 1.21 1.30 ± 0.10 1.50 ± 0.00 1.20 ± 0.20
sucD + 1.00 ± 0.20 1.40 ± 0.30 1.89 ± 0.32 7.16 ± 0.11 1.70 ± 0.20 1.00 ± 0.10 1.10 ± 0.10
Gene Gluconeogenic, glyoxylate and poxB shunt
aceA + 12.00 ± 1.20 1.90 ± 0.20 1.66 ± 0.38 24.20 ± 3.16 9.10 ± 2.80 0.80 ± 0.10 8.81 ± 1.00
aceB + 15.60 ± 2.50 3.70 ± 0.30 2.54 ± 0.09 28.65 ± 5.91 11.00 ± 2.10 0.74 ± 0.00 24.20 ± 2.60
acs 5.60 ± 0.74 8.00 ± 0.13 1.83 ± 0.19 21.82 ± 3.20 4.10 ± 0.10 3.40 ± 0.10 11.90 ± 0.10
glcB + 11.70 ± 1.4 3.70 ± 0.50 1.04 ± 0.28 12.62 ± 0.93 2.50 ± 0.20 1.80 ± 0.20 7.60 ± 0.30
maeB 1.20 ± 0.20 2.50 ± 0.03 1.18 ± 0.26 10.06 ± 1.19 1.60 ± 0.00 1.70 ± 0.00 N.D.
pckA 0.80 ± 0.06 2.30 ± 0.02 0.83 ± 0.21 2.81 ± 0.89 0.90 ± 0.20 1.30 ± 0.10 N.D.
poxB 4.20 ± 0.35 5.70 ± 0.48 3.30 ± 0.48 5.30 ± 0.56 1.50 ± 0.10 0.50 ± 0.00 2.80 ± 0.90
ppsA 3.70 ± 0.21 2.40 ± 0.09 7.34 ± 2.08 5.57 ± 1.34 3.30 ± 0.20 1.10 ± 0.20 N.D.
sfcA 1.90 ± 0.33 1.70 ± 0.10 2.56 ± 0.85 3.72 ± 0.28 1.10 ± 0.10 1.00 ± 0.00 N.D.
Gene gal regulon
galE 38.80 ± 6.80 46.60 ± 6.50 0.53 ± 0.12 40.25 ± 1.97 1.40 ± 0.10 25.00 ± 2.10 N.D.
galK 39.00 ± 2.30 48.21 ± 4.00 2.12 ± 0.09 43.78 ± 3.43 N.D. N.D. N.D.
galM 8.10 ± 3.94 3.30 ± 0.70 0.96 ± 0.18 2.67 ± 0.85 N.D. N.D. N.D.
galP 12.40 ± 1.08 13.10 ± 1.86 1.98 ± 0.36 25.11 ± 0.98 N.D. N.D. 11.70 ± 1.90
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Table 3 RT-qPCR values of central metabolism and regulatory genes (Continued)
galR*** 3.20 ± 0.10 1.20 ± 0.40 2.04 ± 0.25 5.20 ± 0.10 N.D. N.D. N.D.
galS 4.90 ± 0.47 3.20 ± 0.52 4.14 ± 0.35 23.48 ± 0.07 N.D. N.D. N.D.
galT 35.60 ± 2.37 42.50 ± 4.00 1.10 ± 0.12 64.34 ± 5.20 N.D. N.D. N.D.
galU 1.70 ± 0.30 2.10 ± 0.36 1.27 ± 0.01 2.36 ± 0.22 N.D. N.D. N.D.
Gene Respiration
cyoA + 0.60 ± 0.01 1.40 ± 0.07 2.16 ± 0.07 4.33 ± 0.38 N.D. N.D. 1.10 ± 0.10
cyoB + 0.30 ± 0.00 1.40 ± 0.10 2.42 ± 0.58 3.11 ± 0.04 N.D. N.D. N.D.
cyoC + 0.30 ± 0.00 1.20 ± 0.20 2.93 ± 0.19 2.77 ± 0.55 N.D. N.D. N.D.
cyoD + 0.30 ± 0.02 1.10 ± 0.10 1.90 ± 0.43 3.05 ± 0.03 N.D. N.D. N.D.
nuoA + 0.40 ± 0.00 2.40 ± 0.10 3.53 ± 0.54 9.67 ± 1.98 N.D. N.D. 1.00 ± 0.00
nuoF + 0.40 ± 0.10 1.40 ± 0.10 4.68 ± 0.11 6.84 ± 0.28 N.D. N.D. N.D.
nuoN + 0.40 ± 0.02 1.00 ± 0.08 0.44 ± 0.02 1.55 ± 0.18 N.D. N.D. N.D.
ubiE + 0.40 ± 0.00 1.60 ± 0.00 4.39 ± 1.31 12.01 ± 1.26 N.D. N.D. N.D.
Gene ppGpp metabolism
gpp 1.40 ± 1.20 5.20 ± 0.30 9.17 ± 1.65 4.77 ± 0.93 0.00 ± 0.00 0.10 ± 0.00 N.D.
ndk 0.40 ± 0.00 3.10 ± 0.10 3.49 ± 0.52 11.08 ± 0.43 0.50 ± 0.00 3.30 ± 0.10 N.D.
ppa 1.00 ± 0.00 6.10 ± 1.40 7.42 ± 0.33 9.29 ± 0.32 0.50 ± 0.10 3.80 ± 0.10 N.D.
relA 1.30 ± 0.00 1.60 ± 0.20 3.13 ± 0.20 1.51 ± 0.00 0.90 ± 0.10 1.10 ± 0.00 N.D.
spoT 1.10 ± 0.20 4.80 ± 0.20 6.00 ± 0.77 7.36 ± 0.82 0.50 ± 0.10 0.70 ± 0.10 N.D.
Gene pts operon
crr 0.00 ± 0.00 0.00 ± 0.00 2.46 ± 0.37 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
ptsH 0.00 ± 0.00 0.00 ± 0.00 1.07 ± 0.12 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
ptsI 0.00 ± 0.00 0.00 ± 0.00 1.34 ± 0.14 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
Gene Genes in deleted chromosomal fragment in PB12
galR*** 3.20 ± 0.10 1.20 ± 0.40 2.04 ± 0.25 5.20 ± 0.10 N.D. N.D. N.D.
lplT*** 3.95 ± 0.53 0.00 ± 0.00 0.95 ± 0.12 2.83 ± 0.32 N.D. N.D. N.D.
mutH*** 2.76 ± 0.02 0.00 ± 0.00 16.49 ± 0.22 30.48 ± 0.00 N.D. N.D. N.D.
rppH*** 1.84 ± 0.20 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 N.D. N.D. N.D.
ptsP*** 1.80 ± 0.20 0.00 ± 0.00 0.55 ± 0.07 0.30 ± 0.06 N.D. N.D. N.D.
tas*** 1.31 ± 0.07 0.00 ± 0.00 1.07 ± 0.21 12.80 ± 2.44 N.D. N.D. N.D.
ygdQ*** 8.86 ± 1.86 0.00 ± 0.00 1.92 ± 0.06 6.10 ± 1.58 N.D. N.D. N.D.
Gene Genes with point mutations in PB12
arcB** 2.30 ± 0.70 1.30 ± 0.72 0.99 ± 0.06 1.23 ± 0.19 N.D. N.D. N.D.
barA** 4.14 ± 0.91 3.46 ± 0.46 3.25 ± 0.09 2.30 ± 0.53 N.D. N.D. N.D.
rna** 0.89 ± 0.18 3.40 ± 0.75 2.06 + 0.42 8.03 ± 0.00 N.D. N.D. N.D.
rssA** 4.89 ± 1.27 4.04 ± 0.43 6.45 ± 0.31 6.07 ± 0.95 N.D. N.D. N.D.
rpoD** 1.00 ± 0.20 0.90 ± 0.20 1.00 ± 0.20 1.18 ± 0.24 0.70 ± 0.20 1.10 ± 0.10 N.D.
rpoS + 2.90 ± 0.86 2.20 ± 0.20 2.03 ± 0.07 4.62 ± 0.34 0.10 ± 0.00 0.20 ± 0.00 2.60 ± 0.10
yjjU** 0.86 ± 0.26 8.51 ± 0.00 1.44 ± 0.03 4.31 ± 0.35 N.D. N.D. N.D.
ypdA** 1.59 ± 0.49 1.38 ± 0.15 1.20 ± 0.31 1.36 ± 0.11 N.D. N.D. N.D.
Gene Regulators
arcA 1.02 ± 0.02 1.30 ± 0.09 1.68 ± 0.49 3.86 ± 0.60 0.70 ± 0.00 1.10 ± 0.10 0.00 ± 0.00
arcB** 2.30 ± 0.70 1.30 ± 0.72 0.99 ± 0.06 1.23 ± 0.19 N.D. N.D. N.D.
barA** 4.14 ± 0.91 3.46 ± 0.46 3.25 ± 0.09 2.30 ± 0.53 N.D. N.D. N.D.
crp 0.80 ± 0.02 1.00 ± 0.05 1.38 ± 0.01 2.22 ± 0.64 N.D. N.D. N.D.
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Table 3 RT-qPCR values of central metabolism and regulatory genes (Continued)
cyaA 1.40 ± 0.10 1.80 ± 0.10 2.37 ± 0.78 3.62 ± 0.68 N.D. N.D. N.D.
fadR 0.60 ± 0.03 1.60 ± 0.08 3.52 ± 0.03 3.34 ± 0.19 N.D. N.D. N.D.
fruR 1.30 ± 0.00 1.50 ± 0.07 1.41 + 0.02 4.34 + 0.34 N.D. N.D. N.D.
galR*** 3.20 ± 0.10 1.20 ± 0.40 2.04 ± 0.25 5.20 ± 0.10 N.D. N.D. N.D.
iclR 0.40 ± 0.03 1.40 ± 0.07 0.81 ± 0.20 2.62 ± 0.39 N.D. N.D. N.D.
ihfA 1.80 ± 0.04 1.70 ± 0.06 1.97 ± 0.32 2.07 ± 0.22 N.D. N.D. N.D.
ihfB 1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00 N.D. N.D. N.D.
mlc 1.10 ± 0.00 1.70 ± 0.06 2.37 ± 0.49 10.66 ± 2.07 N.D. N.D. N.D.
rpoD** 1.00 ± 0.20 0.90 ± 0.20 1.00 ± 0.20 1.18 ± 0.22 0.70 ± 0.20 1.10 ± 0.10 N.D.
rpoS + 2.90 ± 0.86 2.20 ± 0.20 2.03 ± 0.07 4.62 ± 0.34 0.10 ± 0.00 0.20 ± 0.00 2.60 ± 0.10
Relative mRNA concentrations of central metabolism and regulatory genes of JM101, PB11, PB12 and their derivatives strains, grown in glucose as the sole carbon
source, were determined by RT-qPCR. Most of these values have previously been reported (*) and are presented here for discussion and comparison purposes
[9-11]. ArcA/B regulated genes are marked with (+). Data in this table are reported as relative expression levels of the parental JM101 strain, assigning it the value
of one (see Materials and Methods). The RT-qPCR values of mutated (**) or deleted (***) genes in the PB12 strain have not been reported, with the exception of
arcB and rpoS. N.D. Not determinate.
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increased in the JM101ΔrppH as compared to JM101, but
in general at lower level, with the exception of the gapA,
pgi, glk, sdhA, sdhB, and sucAB genes, which increased
more than 3-fold (Table 3). The RT-qPCR values of some
of the ArcA/B regulated genes were also highly increased in
the PB11ΔrppH (Table 3). When comparing the RT-qPCR
values of central metabolic genes in the PB11ΔrppH strain
with those of the PB12 strain, the TCA cycle genes were
reduced in the PB12 strain (Table 3). The analysis and pos-
sible explanations of these differences is presented in the
next section. Remarkably, RT-qPCR values of most of the
regulatory genes analyzed were also increased and, in some
cases, highly increased in the PB11ΔrppH derivative, as
compared to the parental PB11, whereas RT-qPCR values
of most regulatory genes in the JM101ΔrppH derivativeTable 4 Specific growth rates (μ) of the PB12 strain and
its derivatives
Regulatory genes
Strain μ (h-1) %
PB12 0.44 ± 0.016 100
PB12ΔarcA 0.4 ± 0.0038 91
PB12ΔbarA 0.46 ± 0.001 105
PB12ΔrpoS* 0.38 86
Possible regulatory genes
Strain μ (h-1) %
PB12ΔyjjU 0.34 ± 0.003 77
PB12ΔrssA 0.43 ± 0.018 98
PB12Δrna 0.43 ± 0.035 98
PB12ΔypdA 0.44 ± 0.003 100
*This value has been previously reported [9-11].were not substantially modified as compared to its parental
JM101 strain.
As mentioned, higher RT-qPCR values of most of the
genes in the PB11ΔrppH derivative are mainly the result
of the increase in the mRNA half-life time due to the ab-
sence of RppH. However, since higher levels of most of
the transcriptional regulators were detected in the
PB11ΔrppH strain, it is possible that the enhanced ex-
pression of some genes could be, in addition of
increased mRNA half-life time, the result of higher or
lower expression of their regulatory genes.
Analysis and possible effects of some of the mutated
regulatory and putative regulatory genes in the evolved
PB12 strain
It has previously been proposed that the point mutation
in the arcB gene, detected in the PB12 strain, is appar-
ently responsible for diminishing the ArcA/B function as
a repressor, since it is known that inactivation of ArcB
or enhancing of its ArcA-P dephosphorylating activity,
could contribute to the overexpression of ArcA/B regu-
lated genes [9,20-22]. However, in order to explain the
particularly higher mRNA levels of most of the TCA
cycle and respiratory genes mainly controlled by ArcA/B
in the PB11ΔrppH strain, as compared to the PB12
strain (except for mdh and nuoN; Table 3), we now
propose a different role for this arcB mutation. This mu-
tation is apparently responsible for modifying the ArcA/B
repressor function in the PB12 strain by reducing -not en-
hancing-, its ArcA-P dephosphorylating capacity, which in
turn could contribute to higher repression of ArcA/B
regulated genes, explaining the reduction in the RT-qPCR
values of most of the genes regulated by the ArcA-P
in PB12 as compared to the PB11ΔrppH strain.
Therefore, this change in the arcB gene apparently
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genes [9,20,21], and metabolic burden, allowing bet-
ter growth capacities to the PB12 strain as compared
to the PB11ΔrppH derivative (Table 3). In agreement
with this proposition, the knockout inactivation of
the arcA gene in the PB12ΔarcA strain reduced 10%
the μ (Table 4), because higher transcription levels
of the ArcA/B-controlled genes resulted in this de-
rivative (data not shown) and this was probably
sensed as metabolic burden. The same growth dimin-
ishing effect occurred in the JM101ΔrppH strain,
probably due to higher transcription levels of many
central metabolism genes, including some of the
TCA cycle, which were apparently responsible for re-
ducing 27% the μ (data not shown), as compared to
the parental JM101 strain. In agreement with the im-
portant role of the ArcA/B regulator, inactivation of
arcA in the PB11ΔarcA strain increase substantially
the μ and the transcription levels of most of the
ArcA/B-regulated genes as compared to PB11 strain
[10] (Table 3). From these results, it is tempting to
propose that inactivation of the arcA gene in E. coli
could be used as a tool for allowing better growth
capabilities to cells growing aerobically in certain
stress conditions, in which the lack of regulation of
the TCA cycle and respiratory genes would be an ad-
vantage [9,10].
It has been proposed that YjjU could be involved in
regulatory processes [32,33]. The inactivation of yjjU in
the PB11ΔyjjU strain increased its μ from 0.13 to 0.16 h-1.
This 23% increment is not as high as the values obtained
with the inactivation of arcA (243%) and rppH (261%)
(Table 2). However, yjjU inactivation in the PB12ΔyjjU
strain reduced its μ 23% (from 0.44 to 0.34 h-1), as com-
pared to the parental PB12 strain (Table 4). These results
suggest that if this protein really functions as a regula-
tory factor, as has been proposed, the point mutation
could allow stronger capabilities to the cell for faster
growth in glucose. Cassette inactivation of yjjU is the
only case in which a gene knockout increased the μ in
the PB11ΔyjjU derivative, and reduced the μ in the same
percentage in the PB12ΔyjjU derivative. This mutation
has to be investigated further, initially analyzing the
transcription pattern of critical genes in the strain
PB12ΔyjjU as compared to the parental PB12.
The mutation in the rpoD gene is responsible of a con-
served valine 482 to isoleucine substitution located in
the HTH motif of region 4.2 of RpoD that is involved in
the recognition of the −35 promoter region. In the co-
crystal structure of region 4.2 of Thermus aquaticus with
promoter DNA, which is almost identical to the E. coli,
this position is located at the turn of the HTH motif and
does not make any direct contact with the DNA [36].
Thus, it is likely that this particular substitution doesnot affect the affinity of this sigma subunit for the pro-
moter DNA sequences.
Since the knockout inactivation of the barA, rssA, rna
and ypdA genes did not modify substantially the μ in the
PB11 and PB12 derivatives, it appears that these genes
played minor or not role at all in the growth recovery
observed in the evolved strain.Conclusions
We propose that the deletion event that simultaneously
removed the mutH, rppH, and part of the galR genes,
mainly responsible for the faster growth (4x) in glucose,
occurred as one of the initial events in the adaptive la-
boratory evolution process which resulted in the evolved
PB12 strain. This deletion caused simultaneously: a) a
very high mutagenesis rate due to the removal of mutH,
in a strain lacking PTS that is already responsible of a
carbon stress response, b) higher glucose transport, by
increased levels of GalP in this strain lacking PTS, due
to the inactivation of galR [9,12], and c) higher mRNA
levels resulting in enhanced glycolytic and TCA fluxes
and better respiratory capacity to the precursor of the
PB12 strain due to the absence of RppH.
In addition, lower mRNA levels of most of the ArcA/B
regulated genes were detected in the PB12 strain as
compared to the PB11ΔrppH derivative. This can be
explained as an enhanced ArcA-P repressor capacity due
to the arcB mutation that apparently appeared after the
deletion of the rppH gene in the evolved strain, allowing
lower levels of transcription of ArcA/B-regulated genes.
Knockout inactivation of the barA, rssA, rna and ypdA
genes in the PB11 and in PB12 strains did not modify
substantially the μ of the derivatives, suggesting that
each of these mutations alone apparently played minor
or no roles at all in the growth recovery in the evolved
strain. Some of these changes could in fact be neutral
mutations [48].
From these considerations, the evidences indicate that
the main reasons for fast growth on glucose are appar-
ently the deletion of the rppH, galR, and mutH genes
and, perhaps, the point mutation in the arcB gene.
These two changes could have been fixed in a short
period of time during the fermentation process. Never-
theless, it cannot be ruled out that other point mutation,
as those in the yjjU, or in the barA genes that have not
been completely characterized in this study, could also
play a minor role in the growth recovery in glucose.
In this study, as in others [4,5], we used two different
whole genome sequencing strategies which produced
slightly different results. True changes had to be dis-
cerned from false positives by conventional Sanger se-
quencing. Therefore, it is important to emphasize the
relevance of using more than one genome resequencing
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in the results.
Finally, the results presented here show the physio-
logical plasticity of E. coli and could be useful in the de-
sign of more robust adaptive laboratory evolution
strategies.
Methods
Bacterial strains, growth conditions and recombinant
DNA techniques
E. coli strains JM101 [F’ traD36 proAB+ lacIq
lacZΔM15/supE thi Δ(lac-proAB) rpoS(33 am)], PB11
[JM101Δ(ptsH, ptsI, crr):: kan] and PB12 (PB11, PTS-
Glc+) and derivatives have previously been described
[7,9-11,38,39]. The derivatives of these strains utilized in
this report, in which the barA, yjjU, rssA, rna, ypdA, and
rppH genes were knockout inactivated, were obtained by
the Datsenko and Wanner method [46], using the oligonu-
cleotides listed in table S3 presented in Additional file 4.
All gene disruptions were confirmed by PCR (data not
shown). For inoculums preparations, strains stored at
−72°C in glycerol were inoculated into Luria broth
(LB) for overnight growth.
The culture of the PB12 strain that was also utilized
for preparing the DNA for genome sequencing, was
obtained from the original culture that has been kept
frozen in glycerol (Figure 1) [10]. For μ determinations,
cells were grown in LB and then inoculated into M9
minimal medium with 2 g/l of glucose as the only car-
bon source; when the cultures were growing exponen-
tially, they were inoculated into the same prewarmed
(50 ml) medium at 37°C and stirred at 300 rpm with a
starting optical density at 600 nm (O.D.600nm)= 0.1. O.
D.600nm were measured using a Klett/Summerson photo-
colorimeter, model 800–3. All specific growth rate values
presented in Tables 2 and 4 are the averages of at least
two independent cultures, each one in duplicate. For
RNA isolation and RT-qPCR analyses, duplicate cultures
were grown on 1 L fermentors on M9 medium with 2 g/l
of glucose as the sole carbon source, at 37°C, stirred at
600 rpm and air flow rate at 1 vvm, with a starting O.
D.600nm = 0.1. For RT-qPCR determinations cells of the dif-
ferent fermentations were collected in the log phase at O.
D.600nm = 1 [9].
DNA extraction from parental and evolved PB12 strains
for genomic analysis
Two overnight cultures of the E. coli strains JM101,
PB11 and PB12 were grown from their frozen original
stocks in liquid LB medium. One set of these cultures
(not including PB11) of these strains was utilized for
DNA purification submitted to RN, and the DNA of the
other set was submitted to the UNAM Massive Sequen-
cing Unit, for genome resequencing (see below). DNAwas extracted by a maxiprep phenol extraction and etha-
nol precipitation method [49] and purified with the Pure
Link PCR purification kit (Invitrogen, USA). Quality and
quantity of extracted DNA was verified as recommended
by RN and by UNAM Massive DNA Sequencing Unit.Roche NimbleGen Inc. sequencing
DNA samples from the JM101 and PB12 strains were
submitted to RN for CGS analysis using E. coli K-12
MG1655 (ATC #47076) as the reference strain [40]. The
results provided by RN are included in Table 1, Figure 2
and in table S1 presented in Additional file 1.Paired and paired end (PE) library construction and GAIIx
sequencing
DNA samples from the JM101, PB11 and PB12 strains
were submitted to the Massive DNA Sequencing Unit of
UNAM for its paired ended (PE) library construction
and genome sequencing. PE library was constructed fol-
lowing Illumina Inc. recommendations. Briefly, 5 μg of
chromosomal DNA of each strain was fragmented by ni-
trogen nebulization during 6 min at a pressure of 32 psi.
Fragmented DNA was purified using the QIAquick PCR
purification kit and resuspended in 30 μl of elution buf-
fer (EB: 10 mM TrisHCl, pH 8.5). DNA end repairs
were performed using a mixture of T4 and Klenow DNA
polymerases and T4 polynucleotide kinase for 5’ ends. In
order to facilitate the ligation of double stranded adap-
ters, an adenine residue was incorporated at each 3’ end
of fragmented DNA before this step using a Klenow exo
minus (exo-) enzyme and dATP. Illumina Inc. adapters
with overhang thymine residues at 3’ ends were ligated
at each end of fragmented DNA using 2x rapid ligation
buffer (Illumina Inc.) and T4 DNA ligase during 15 min
at room temperature. Ligated DNA was purified using a
Qiagen MinElute purification kit (Qiagen, USA) and
resuspended in 15 μl of EB. Modified DNA pool was
loaded on a 2% gel of Ultra Low Range Agarose (Bio
Rad Laboratories USA) and 500 bp DNA fragments
were purified using a QIAquick gel extraction kit. To en-
rich the adapter-modified DNA fragments, purified
DNA was used as template for a 12-cycle PCR reaction
(98, 65 and 72°C), using PCR primers PE 1.0 and 2.0 and
Phusion DNA polymerase (included in the Illumina Inc.
PE sample prep kit). PCR products were purified using a
QIAquick PCR purification kit (Qiagen, USA) and eluted
in 50 μl of EB. Validation and quantification of the li-
braries were performed using an Agilent Bioanalyzer
2100 (DNA 1000 chip). Finally, 18 pM of DNA library
were used for a PE sequence of 2x36 cycles on a GAIIx
instrument that performs sequencing by a synthesis
method based on reversible fluorescent terminators
accordingly to Illumina, Inc.
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Winter Genomics Inc
Low quality reads produced by the Illumina GAIIx
method were filtered using the ShortRead 1.8.0 package
[50]. Assembly for each strain was performed with the
PE-Assembler 1.1 [51]. IMAGE 2.1 [52] was used to
close gaps as it locally assembles reads aligning to contig
ends. Bowtie 0.12.5 short read aligner [53] was used to
align reads to the resulting contigs and unsupported
bases were removed with the Biostrings 2.18.0 package.
Contigs were re-ordered along the E. coli K12 MG1655
genome [40] by using the Mauve 2.3.1. software [54,55].
Then contigs were compared against the reference gen-
ome using both Mauve and Murasaki 1.68.6. softwares
[56]. Using the PTS operon deletion as marker, it was
possible to correctly identify each strain. BLAT v34 soft-
ware [57] was used to perform alignments of strain
PB12, against JM101. VarScan 1.2 software [58] was used
to identify variants using the BLAT alignments as input.
Ambiguous variants were filtered out using a custom
Perl script. For most of the analyses local cluster
resources of the Instituto de Biotecnología-UNAM were
used. The results provided by WG for JM101 and PB12
strains are included in Table 1 and in table S2 presented
in Additional file 2. None of the point mutations
detected in PB12 appeared in the genomic sequencing of
the PB11 strain (data not shown).
DNA sequencing of putative mutations by Sanger
methodology
DNA regions containing putative mutations in regula-
tory genes detected by RN and WG were PCR amplified
using oligonucleotide primers listed in table S3 pre-
sented in Additional file 4, purified by the Pure Link
PCR purification kit and sequenced by the Sanger meth-
odology with the Taq FS Dye Terminator Cycle Sequen-
cing Fluorescence-Based Sequencing, in a Perkin Elmer/
Applied Biosystems Model 3730. Sequence differences of
14 of the mutations presented in Table 1A were confirmed
by examination of the trace data (data not shown).
RNA Extraction, DNAse treatment of RNA and cDNA
synthesis for RT-qPCR analysis
Total RNA from the utilized strains was isolated and
purified using the hot-phenol method, with some modi-
fications. Samples containing 50 ml of the different
strains growing logarithmically in the fermentor were
collected at 1 OD600nm. 1 ml of RNA later buffer
(Ambion Inc., USA) was added to each sample, mixed
and centrifuged 10 min/4°C/5000 rpm. Cells were resus-
pended with 1 ml of buffer I (0.3 M sucrose, 0.1 M sodium
acetate), treated with 20 μl of lysozyme (10 mg/ml in TE
buffer) for 10 min at room temperature. 2 ml of buffer II
(0.01 M sodium acetate, 2% SDS) were added and themixtures incubated for 3 min at 65°C. The lysates were
extracted with 2 ml of hot phenol and heated for 3 min at
65°C. A second extraction with hot phenol was performed
without heating the mixtures. Samples were then
extracted with 2 ml of a phenol:chloroform mixture (1:1),
precipitated with 0.1 volume of 3 M sodium acetate (pH
5.2) and 2.5 volume of ethanol and centrifuged for 15 min
at 4°C/10000 rpm. Samples were then suspended in 300 μl
of DNAse and RNase-free water (Ambion Inc, USA) with
RNase inhibitor (Fermentas Life Sciences, USA) and
extracted twice with 1 volume of chloroform. Finally, sam-
ples were precipitated as before and suspended in 300 μl
of TE buffer (Ambion Inc, USA). RNA was analyzed on for-
maldehyde agarose gel for integrity. RNA concentrations
were quantified using Nanodrop 2000c (Thermo Scientific);
the 260nm/280nm and 260nm/230nm ratios were examined
for protein and solvent contamination. For all samples the
260nm/280nm absorbances values were between 1.9-2.0 and
in the range of 2.0-2.3 for the 260nm/230nm ratio. RNA
samples were stored at −70°C. Three RNA extractions and
purifications were carried out from three independent fer-
mentations for each strain.
For DNAse treatment, total RNA samples were treated
with TURBO DNA-free kit (Ambion Inc, USA) at 37°C
for 30 min, following manufacturer’s instructions. To de-
termine whether RNA samples were significantly con-
taminated with genomic DNA, samples were subjected
to conventional PCR with primers for the arcA gene
(Table S3 presented in Additional file 4). Since these pri-
mers were designed to recognize genomic DNA, the
presence of a detectable PCR product on an ethidium
bromide-stained agarose gel confirmed that the specific
RNA sample was contaminated with genomic DNA.
Contaminated samples were discarded. PCR reactions
were performed with Taq polymerase (Fermentas Life
Sciences, USA). The cycling parameters were: 95°C for
5 min, 30 cycles at 95°C for 1 min, 55°C for 1 min and
72°C for 1 min plus an extension step at 72°C for
5 min. Additionally, the DNAse-treated RNA sam-
ples were used for RT-qPCR analyses of the same
arcA gene, using the appropriate oligos [arcAa (for-
ward) and arcAb (reverse)] (Table S3 presented in
Additional file 4). As in the PCR case, all utilized
samples did not produce a 101 bp amplimer, indicat-
ing that small fragments of genomic DNA were not
present. cDNA was synthesized using RevertAidTM H
minus First Strand cDNA Synthesis kit following the
manufacturer´s instructions (Fermentas LifeSciences,
USA.). For each reaction approximately 5 μg of RNA
and a mixture of 10 pmol/μl of specific DNA reverse
primers (b) for the utilized genes, were used. Nu-
cleotide sequences of these genes have been previ-
ously published [9-11] or are listed in table S3
presented in Additional file 4. cDNA were used as
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sized using specific oligonucleotides, since this con-
dition ensures the synthesis of only one copy of
cDNA per each RNA molecule [9,59].
RT-qPCR
RT-qPCR was performed with the ABI Prism 7000 Se-
quence Detection System and 7300 Real Time PCR Sys-
tem (Perkin Elmer/Applied Biosystems, USA) using the
MaximaR SYBR Green/ROX qPCR Master Mix (2X) kit
(Fermentas LifeSciences, USA). MicroAmp Optical 96-
well reaction plates (Applied Biosystems, USA) and Plate
Max ultraclear sealing films (Axygen Inc, USA) were
used in these experiments. Amplification conditions
were 10 min at 95°C, followed by a two-step cycle at
95°C for 15 sec and 60°C for 60 sec for a total of
40 cycles, to finish with a dissociation protocol (95°C
for 15 sec, 60°C for 1 min, 95°C for 15 sec and 60°C
for 15 sec). DNA sequences of the primers for spe-
cific amplifications were designed using the Primer
Express software (Perkin Elmer/Applied Biosystems,
USA). Some of these sequences have been previously
published [9-11] and the rest are included in table S3
presented in Additional file 4. All RT-qPCR experi-
ments complied with the MIQE guidelines (Minimum
Information for Publication of Quantitative Real-Time
PCR Experiments) [60,61]. The length of all the uti-
lized oligonucleotides (forward and reverse), was be-
tween 18 and 21 nucleotides, with % of GC between
45 to 60 and Tm between 58 to 60°C. The size of all
amplimers was 101 bp. The final primer concentra-
tion was 0.2 μM, in a total volume of 12 μl. Five ng
of target cDNA for each gene were added to the reac-
tion mixture, since higher cDNA concentrations
(>10 ng) are not in the dynamic range of the refer-
ence ihfB gene (see below). Hence the obtained values
cannot be correctly normalized for this higher cDNA
concentration. All experiments were performed at
least in triplicate from three different fermentations,
for each gene of each strain, obtaining very similar
values (differences <0.3 SD). A non-template control
reaction mixture was included for each gene and
values appeared for all genes after cycle 31. Standard
curves were constructed to evaluate PCR efficiency
and all the genes had R2 values above 0.9976 with
slopes between −3.4 to −3.7. The quantification tech-
nique used to analyze data was the 2-ΔΔCq method
described by Livak and Shmittgen [62]. Data were
normalized using the ihfB gene as an internal control
(reference gene). The same reproducible expression
level of this gene was detected in all the strains in
the conditions in which bacteria were grown and ana-
lyzed, since this is the most important characteristic
that a reference gene should have in accordance withthe MIQE guidelines. Additional file 5 (Figure S2) presents
the ihfB gene values detected for the utilized strains. These
results demonstrate the stability of the expression of this
reference gene in all the analyzed derivatives for the used
conditions in this report and also on previous reports util-
izing these strains and other derivatives [9-11,60].
For each analyzed gene in all strains the transcription
level of the corresponding JM101 gene, was considered
equal to one, and it was used as control to normalize the
data. Therefore, data are reported as relative expression
levels, compared to the expression level of the same
gene in the JM101 strain. Results presented in Table 3
are the averages of at least three independent measure-
ments of the RT-qPCR expression values for each gene.
Values were obtained from different cDNAs generated
from two independent bioreactor samples [9].Additional files
Additional file 1: Table S1. Mutations in coding regions detected by
Roche NimbleGen Inc. This table includes the data provided by Roche
NimbleGen Inc. (RN) for the whole genome sequence analysis of the
evolved PB12 strain. Section A lists 26 (21+5) non-synonymous point
mutations in structural genes that accordingly to RN changed the coding
regions of these genes. In fact only in 21 of these genes detected also by
Winter Genomics Inc (WG), the mutations occurred (Table 1A). Section B
presents the list of the 12 genes included in a large deletion in this
strain. This list also includes the genes deleted in the parental PB11 strain,
for the construction of this derivative lacking PTS (Figure 2). The table
also includes (Section C), the list of the 20 genes in which synonymous
point mutations occurred accordingly to RN. Those 16 in common with
WG are in bold letters.
Additional file 2: Table S2. Mutations in coding regions detected by
Winter Genomics Inc. This table lists the data provided by Winter
Genomics Inc. (WG) obtained for the whole genome sequence of the
PB12 strain in comparison to the parental strains JM101 and PB11.
Importantly, PB11 strain was sequenced by WG and the same nucleotide
sequences as in the parental strain JM101 were determined (data not
shown). Therefore all the point mutations detected in PB12 by RN and
WG appeared during the laboratory evolution process. Section A includes
a list of 27 genes (21+6) in which, accordingly to this company non-
synonymous point mutations occurred changing the coding regions in
structural genes. 21 of these genes were also detected by RN (Table 1A).
The table also includes (Section B) the list of 18 genes in which
synonymous mutations also occurred, accordingly to WG. Those 16 in
common with RN are in bold letters.
Additional file 3: Figure S1. Nucleotide sequence of the chromosomal
genes fusion that occurred in the evolved PB12 strain. This figure
includes the nucleotide sequence of the genomic region where the
deletion occurred (Figures 3 and 4) between the ptsP and the galR genes
in the PB12 strain.
Additional file 4: Table S3. Oligonucleotides employed in this study.
This table lists the oligonucleotides utilized in this work. Section A shows
the oligonucleotides used for DNA sequencing with the Sanger method,
including those for the confirmation of the deletion that occurred in the
PB12 strain (Figures 2, 3 and 4), the reported mutations provided by RN
and WG (Table 1 and Tables S1 and S2 in Additional file 1 and Additional
file 2) and the ones employed for gene disruption confirmation. Section
B lists the oligos utilized for gene disruption with the Datsenko-Wanner
methodology [46]. Section C lists the oligonucleotides utilized for
RT-qPCR analysis not previously reported. The sequences of the oligos
utilized for the remaining genes listed in Table 3, have been previously
published [9-11] (see Materials and Methods).
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different strains. This figure shows the positions of the amplification
curves for the ihfB gene (Section A) and the Ct values of this gene
(Section B), in the different strains employed in this study. As can be
seen, all the amplification curves of the ihfB gene that has been used as
the reference gene for the determination of the RT-qPCR levels, have
very similar values. The values presented in the table are from three
different fermentations (F1, F2 y F3) for each utilized strain. Since all the
values included in section B are very similar, only one third of them are
presented (labeled with an asterisk *) in section A. These results
demonstrate that the same reproducible expression levels were obtained
for the ihfB gene in all strains. This is the most important characteristic
that a reference gene should have, in agreement to the MIQE guidelines
[59-61]. These results corroborate the stability of the expression of the
reference ihfB gene in these strains in the utilized conditions.
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